Called mezigdomide, the drug is one of two protein-degrading medicines Bristol Myers hopes to soon position as successors to ...

Roswell Park researchers at ASCO 2026 report GLP-1 links to breast cancer risk, CAR T safety in older myeloma patients, and ...

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem ...

A few years ago, a patient was cured of multiple myeloma after being treated for hepatitis C, astounding researchers from the group led by Joaquín Martínez, from the H12O-CNIO Hematological Tumours ...

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled ...

The multiple myeloma market is evolving toward immunotherapy-dominated, multi-line treatment paradigms with strong growth driven by CAR-T and bispecific antibodies. Leading contenders advancing ...

In this video, Adriana Rossi, MD, assistant professor of medicine at Mount Sinai, discusses future research directions in multiple myeloma.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseq TM, a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma.

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...